Full Report
View CSAF 1. EXECUTIVE SUMMARY CVSS v4 5.1 ATTENTION: Low attack complexity/public exploits are available Vendor: BPL Medical Technologies Equipment: PWS-01-BT, Be Well Android App Vulnerability: Cleartext Transmission of Sensitive Information 2. RISK EVALUATION Successful exploitation of this vulnerability could allow an attacker to intercept and modify information as it being processed 3. TECHNICAL DETAILS 3.1 AFFECTED PRODUCTS The following BPL Medical Technologies products are affected: Be Well Android Application: Versions 3.64 and prior PWS-01-BT: All versions 3.2 Vulnerability Overview 3.2.1 Cleartext Transmission of Sensitive Information CWE-319 BPL Personal Weighing Scale PWS-01BT IND/09/18/599 devices send sensitive information in unencrypted BLE packets. (The packet data also lacks authentication and integrity protection.) CVE-2024-34463 has been assigned to this vulnerability. A CVSS v3.1 base score of 4.6 has been calculated; the CVSS vector string is (AV:A/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:N). A CVSS v4 score has also been calculated for CVE-2024-34463. A base score of 5.1 has been calculated; the CVSS vector string is (CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N). 3.3 BACKGROUND CRITICAL INFRASTRUCTURE SECTORS: Healthcare and Public Health Sector COUNTRIES/AREAS DEPLOYED: Worldwide COMPANY HEADQUARTERS LOCATION: India 3.4 RESEARCHER Yash Chandna and Hanit Thakur reported this vulnerability to CISA. 4. MITIGATIONS BPL Medical Technologies has not responded to requests to work with CISA to mitigate these vulnerabilities. Users of the affected products are encouraged to contact BPL Medical Technologies support for additional information. CISA recommends users take defensive measures to minimize the risk of exploitation of this vulnerability, such as: Minimize network exposure for all control system devices and/or systems, ensuring they are not accessible from the internet. Locate control system networks and remote devices behind firewalls and isolating them from business networks. When remote access is required, use more secure methods, such as Virtual Private Networks (VPNs), recognizing VPNs may have vulnerabilities and should be updated to the most current version available. Also recognize VPN is only as secure as the connected devices. CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures. CISA also provides a section for control systems security recommended practices on the ICS webpage on cisa.gov/ics. Several CISA products detailing cyber defense best practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies. CISA encourages organizations to implement recommended cybersecurity strategies for proactive defense of ICS assets. Additional mitigation guidance and recommended practices are publicly available on the ICS webpage at cisa.gov/ics in the technical information paper, ICS-TIP-12-146-01B--Targeted Cyber Intrusion Detection and Mitigation Strategies. Organizations observing suspected malicious activity should follow established internal procedures and report findings to CISA for tracking and correlation against other incidents. CISA also recommends users take the following measures to protect themselves from social engineering attacks: Do not click web links or open attachments in unsolicited email messages. Refer to Recognizing and Avoiding Email Scams for more information on avoiding email scams. Refer to Avoiding Social Engineering and Phishing Attacks for more information on social engineering attacks. No known public exploitation specifically targeting this vulnerability has been reported to CISA at this time. This vulnerability is not exploitable remotely. 5. UPDATE HISTORY September 10, 2024: Initial Publication
Analysis Summary
# Vulnerability: Cleartext Transmission in BPL Medical Devices via BLE
## CVE Details
- CVE ID: CVE-2024-34463
- CVSS Score: 5.1 (Medium - v4 score) / 4.6 (Low - v3.1 score) (Note: The v3.1 score of 4.6 is used for severity context, but the provided summary highlights the v4 score of 5.1.)
- CWE: Cleartext Transmission of Sensitive Information
## Affected Systems
- Products: BPL Personal Weighing Scale (PWS-01-BT), Be Well Android Application
- Versions: Be Well Android Application versions 3.64 and prior; PWS-01-BT: All versions
- Configurations: Transmission via unencrypted Bluetooth Low Energy (BLE) packets.
## Vulnerability Description
The BPL Personal Weighing Scale (PWS-01-BT) transmits sensitive information over unencrypted Bluetooth Low Energy (BLE) packets. This data transmission lacks authentication and integrity protection, allowing an attacker to intercept and potentially modify the processed information.
## Exploitation
- Status: PoC available (Mentioned as "public exploits are available" in the executive summary, though CISA later states "No known public exploitation specifically targeting this vulnerability has been reported to CISA at this time.")
- Complexity: Low (Based on public exploit availability and low attack complexity score (AC:L))
- Attack Vector: Adjacent (AV:A in CVSS)
## Impact
- Confidentiality: Low (C:L)
- Integrity: Low (I:L)
- Availability: None (A:N)
## Remediation
### Patches
- No vendor-supplied patches or updates are specified in the summary. BPL Medical Technologies has not responded to requests to work with CISA on mitigation.
### Workarounds
CISA recommends the following defensive measures:
1. Minimize the network exposure for all control system devices, ensuring they are not accessible from the internet.
2. Locate control system networks and remote devices behind firewalls and isolate them from business networks.
3. Use more secure methods, such as Virtual Private Networks (VPNs), for required remote access.
## Detection
- **Indicators of compromise:** Interception or modification of BLE communication between the PWS-01-BT and the Android application.
- **Detection methods and tools:** Monitoring of BLE traffic using specialized sniffing tools to identify unencrypted transmission of sensitive data originating from the devices.
## References
- Vendor advisory: None published directly in the summary. Users should contact BPL Medical Technologies support.
- Relevant links:
- hxxps://github[.]com/cisagov/CSAF (Main document source)